Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

During the Trading Day
2.38 -0.18 / -7.03%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.36 -0.02 / -0.84%
Volume: 1.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues3.1M3.1M3.4M2.9M
Cost of Goods Sold275.2K253.9K486.2K173.7K
Depreciation And Amortization14.7K10.4K9.1K6.6K
Operating ExpensesGross Income2.8M2.8M2.9M2.8M
General Expenses12.4M10.7M8.3M7.8M
Research And Development9.0M8.6M6.3M4.8M
Total Operating Expenses12.7M11.0M8.8M7.9M
Non-Operating ExpensesOperating Income-9.6M-7.9M-5.4M-5.0M
Extraordinary Credit0.000.000.00189.6K
Interest Expense On Debt0.000.00--86.8K
Other Expenses-39.9K-39.1K-27.0K-24.6K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.7M-7.9M-5.5M-4.9M
Income Taxes0.00-289.8K-555.0K-316.8K
Net Income-9.7M-7.6M-4.9M-4.6M
Shares To Calculate EPSShares To Calculate EPS32.7M33.2M34.1M35.3M
Shares To Calculate EPS Diluted32.7M33.2M34.1M35.3M
Earnings Per ShareEPS-$0.30-$0.23-$0.14-$0.13
EPS Diluted-$0.30-$0.23-$0.14-$0.13